Notice Title

Consent to the Distribution of New Medicines

Publication Date
12 Jun 2025

Tags

Medicines Act Consent to the distribution of new medicines Health

Notice Number

2025-go3126
Title
View PDF
File Type and Size
PDF (36 KB)

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines are set out in the Schedule hereto:

Schedule

Product: Enerlyte (apple and blackcurrant flavour)
Active Ingredients: Glucose 3.56g
Potassium chloride 0.3g
Sodium chloride 0.47g
Sodium citrate dihydrate 0.53g
Dosage Form: Powder for oral solution
New Zealand Sponsor: Maple Healthcare Limited
Manufacturer: Solistaa Pharmaceuticals Pvt. Limited., Puducherry, India
   
Product: Enerlyte (orange flavour)
Active Ingredients: Glucose 3.56g
Potassium chloride 0.3g
Sodium chloride 0.47g
Sodium citrate dihydrate 0.53g
Dosage Form: Powder for oral solution
New Zealand Sponsor: Maple Healthcare Limited
Manufacturer: Solistaa Pharmaceuticals Pvt. Limited., Puducherry, India
   
Product: Pamol (orange flavour)
Active Ingredient: Paracetamol 50mg/mL
Dosage Form: Oral suspension
New Zealand Sponsor: Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Manufacturers: Aspen Pharma Pty Limited, Melbourne, Australia
Ensign Laboratories Pty Limited, Melbourne, Australia
   
Product: Pamol (strawberry flavour)
Active Ingredient: Paracetamol 50mg/mL
Dosage Form: Oral suspension
New Zealand Sponsor: Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Manufacturers: Aspen Pharma Pty Limited, Melbourne, Australia
Ensign Laboratories Pty Limited, Melbourne, Australia
   
Product: Rehydral (apple and blackcurrant flavour)
Active Ingredients: Glucose 3.65g
Potassium chloride 0.3g
Sodium chloride 0.47g
Sodium citrate dihydrate 0.53g
Dosage Form: Powder for oral solution
New Zealand Sponsor: Maple Healthcare Limited
Manufacturer: Solistaa Pharmaceuticals Pvt. Limited, Puducherry, India
   
Product: Rehydral (orange flavour)
Active Ingredients: Glucose 3.65g
Potassium chloride 0.3g
Sodium chloride 0.47g
Sodium citrate dihydrate 0.53g
Dosage Form: Powder for oral solution
New Zealand Sponsor: Maple Healthcare Limited
Manufacturer: Solistaa Pharmaceuticals Pvt. Limited, Puducherry, India


Dated this 9th day of June 2025.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).